Mesenchymal stem cell adhesion to cardiac microvascular endothelium: Activators and mechanisms

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 4, 2006, Pages

  Segers, Vincent F M ^a   Van Riet, Ivan ^b   Andries, Luc J ^c   Lemmens, Katrien ^a   Demolder, Marc J ^a   De Becker, Ann J M L ^b   Kockx, Mark M ^c   De Keulenaer, Gilles W ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c HistoGeneX NV   (Belgium)

Author keywords

Cardiac regeneration; Heart failure

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; MONOCLONAL ANTIBODY; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL BEHAVIOR; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; FLOW RATE; GENETIC TRAIT; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHEAR STRESS; ANIMAL; CELL CULTURE; COCULTURE; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION; CELLS, CULTURED; COCULTURE TECHNIQUES; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; INTERCELLULAR ADHESION MOLECULE-1; MESENCHYMAL STEM CELLS; MICROCIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33646112920     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00523.2005     Document Type: Article

References (31)

1. Adamopoulos S, Parissis JT, and Kremastinos DT. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail 3: 517-526, 2001.
2. Ball SG, Shuttleworth AC, and Kielty CM. Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol 36: 714-727, 2004.
3. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, and Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863-868, 2003.
4. Blau HM, Brazelton TR, and Weimann JM. The evolving concept of a stem cell: entity or function? Cell 105: 829-841, 2001.
5. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83: 59-115, 2003.
6. Davani S, Marandin A, Mersin N, Royer B, Kantelip B, Herve P, Etievent JP, and Kantelip JP. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108, Suppl 1: II253-II258, 2003.
7. Frangogiannis NG, Smith CW, and Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
8. - transport. Cardiovasc Res 63: 700-708, 2004.
9. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, and Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368, 2005.
10. Goette A, Jentsch-Ullrich K, Lendeckel U, Rocken C, Agbaria M, Auricchio A, Mohren M, Franke A, and Klein HU. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide? Circulation 108: 2446-2449, 2003.
11. Hendrickx J, Doggen K, Weinberg EO, Van Tongelen P, Fransen P, and De Keulenaer GW. Molecular diversity of cardiac endothelial cells in vitro and in vivo. Physiol Genomics 19: 198-206, 2004.
12. Imai K, Kobayashi M, Wang J, Ohiro Y, Hamada J, Cho Y, Imamura M, Musashi M, Kondo T, Hosokawa M, and Asaka M. Selective transendothelial migration of hematopoietic progenitor cells: a role in homing of progenitor cells. Blood 93: 149-156, 1999.
13. Konstantopoulos K, Kukreti S, and McIntire LV. Biomechanics of cell interactions in shear fields. Adv Drug Delivery Res 33: 141-164, 1998.
14. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, and Robey PG. Circulating skeletal stem cells. J Cell Biol 153: 1133-1140, 2001.
15. Lim YC, Garcia-Cardena G, Allport JR, Zervoglos M, Connolly AJ, Gimbrone MA Jr, and Luscinskas FW. Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment. Am J Pathol 162: 1591-1601, 2003.
16. Lu L, Chen SS, Zhang JQ, Ramires FJ, and Sun Y. Activation of nuclear factor-κB and its proinflammatory mediator cascade in the infarcted rat heart. Biochem Biophys Res Commun 321: 879-885, 2004.
17. Ma XL, Lefer DJ, Lefer AM, and Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86: 937-946, 1992.
18. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, and Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705, 1999.
19. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91: 988-998, 2002.
20. Mantovani A, Bussolino F, and Dejana E. Cytokine regulation of endothelial cell function. FASEB J 6: 2591-2599, 1992.
21. Netelenbos T, van den BJ, Kessler FL, Zweegman S, Merle PA, van Oostveen JW, Zwaginga JJ, Huijgens PC, and Drager AM. Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cells. Leukemia 17: 175-184, 2003.
22. Pittenger MF and Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20, 2004.
23. Rombouts WJ and Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17: 160-170, 2003.
24. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, and Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156, 2005.
25. Solanilla A, Grosset C, Duchez P, Legembre P, Pitard V, Dupouy M, Belloc F, Viallard JF, Reiffers J, Boiron JM, Coulombel L, and Ripoche J. Flt3-ligand induces adhesion of haematopoietic progenitor cells via a very late antigen (VLA)-4- and VLA-5-dependent mechanism. Br J Haematol 120: 782-786, 2003.
26. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994.
27. Tanaka M, Brooks SE, Richard VJ, FitzHarris GP, Stoler RC, Jennings RB, Arfors KE, and Reimer KA. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Circulation 87: 526-535, 1993.
28. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, Shi J, Yang YZ, Pan C, Ge J, and Phillips MI. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117: 3-10, 2004.
29. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, and Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120: 999-1005, 2000.
30. Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, and Cramer DV. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 75: 679-685, 2003.
31. Yong KL, Watts M, Shaun TN, Sullivan A, Ings S, and Linch DC. Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31). Blood 91: 1196-1205, 1998.